newsfilter
← Latest News
Business Wire·

Quanterix Announces Landmark Nature Study Redefining Alzheimer's Disease Neuropathology Prevalence

Simoa p-Tau 217 Assay Enables Largest Population-Based Assessment (11,000+ Samples) Revealing Striking Age-Related Increase and Broad Treatment Eligibility Quanterix Corporation (NASDAQ:QTRX), a company transforming